Table 4.
Risk factors associated with anaemia (<11 g/dl).
| Factor level | Risk factor | Crude OR | Adjusted OR | (95% CI) | P-value |
|---|---|---|---|---|---|
| Background | Age (continuous per year) | 1.0 | 0.98 | (0.93–1.04) | .51 |
| District of residence | |||||
| Kampala | 1.0 | 1.0 | |||
| Wakiso | 1.15 | 1.11 | (0.60–2.07) | .74 | |
| Other | 0.40 | 0.44 | (0.13–1.52) | .20 | |
| Education (continuous per level) | 1.14 | 1.14 | (0.73–1.77) | .57 | |
| Intermediate | Gravidity | ||||
| G1 | 1.0 | 1.0 | |||
| G2-3 | 1.04 | 1.0 | (0.56–1.80) | .98 | |
| ≥G4 | 0.86 | 0.70 | (0.30–1.63) | .51 | |
| Placental malaria (active + past) | 2.31* | 2.35 | (1.27–4.35) | .006 | |
| Active infection | 2.66* | 2.76 | (1.40–5.45) | .003 | |
| Past infection | 1.37 | 1.53 | (0.44–4.66) | .48 | |
| Proximate | Used bednet | 0.73 | 0.67 | (0.37–1.20) | .18 |
| Received IPT | |||||
| None | 1.0 | 1.0 | |||
| 1 dose of SP | 1.05 | 1.17 | (0.64-2.13) | .62 | |
| 2 doses of SP | 1.46 | 1.17 | (0.47-2.86) | .74 | |
| Iron supplementation | 1.51 | 1.96 | (0.67-5.71) | .22 | |
| Folic acid supplementation | 1.26 | 0.70 | (0.29-1.71) | .43 |
*Significant associations (P < .05).